Premium
Percutaneous mitral balloon valvuloplasty in pregnant women with mitral stenosis
Author(s) -
Nercolini Deborah Christina,
Bueno Ronaldo da Rocha Loures,
Eduardo Guérios Ênio,
Tarastchuk José Carlos,
Pacheco Álvaro Luis,
Andrade Paulo Mauricio Piá de,
Cunha Claudio Leinig Pereira da,
Germiniani Hélio
Publication year - 2002
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.10225
Subject(s) - medicine , stenosis , percutaneous , balloon , mitral valve , gestational age , pregnancy , mitral valve stenosis , cardiology , mitral valvuloplasty , surgery , gestation , biology , genetics
Forty‐four consecutive pregnant patients with mitral stenosis were submitted to percutaneous mitral valvuloplasty (PMV) over a period of 12 years. The mean age was 28 ± 6 years and the mean gestational age was 23 ± 6 weeks. The mean mitral valve area had a significant increase from 1.17 ± 0.26 to 2.06 ± 0.41 cm 2 ( P = 0.0000). The mean mitral valve gradient decreased from 16.22 ± 5.55 to 7.94 ± 3.75 mm Hg ( P = 0.0001). The procedure was performed successfully in 95% of the patients and there were no major complications. Concerning labor and delivery, we evaluated 37 patients. Thirty patients (81%) reached term and delivered normal infants. Seven patients (18.9%) delivered prematurely, resulting in two fetal death; one patient delivered a stillborn. We concluded that PMV is a safe procedure for the treatment of mitral stenosis in pregnant patients, providing significant symptomatic relief and better clinical conditions for labor and delivery. Cathet Cardiovasc Intervent 2002;57:318–322. © 2002 Wiley‐Liss, Inc.